Y-mAbs Therapeutics, Inc.
Disclosed SEC business address
202 CARNEGIE CENTER, SUITE 301, PRINCETON, NJ, 08540
Y-mAbs Therapeutics, Inc. (ticker CIK0001722964, CIK 0001722964) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 2 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-24T11:06:01.627918+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:33:13.852720+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:33:18.252531+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:33:22.232557+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.